Pulmonary embolism after dexamethasone treatment for COVID-19: a case report

Pulmonary embolism after dexamethasone treatment for COVID-19: a case report

Abstract Background Although the RECOVERY trial showed that dexamethasone was efficacious for the treatment of coronavirus disease 2019 (COVID-19), its impact on the risk of pulmonary embolism (PE) and other serious procoagulant events was not assessed. Case presentation Here we report the case of a...

Full description

Bibliographic Details
Main Authors: Hidenori Takahashi, Yoshinobu Iwasaki, Takayasu Watanabe, Naoki Ichinose, Toshimi Oda
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Pulmonary embolism
Anticoagulation
Dexamethasone
Cytokine
Online Access:https://doi.org/10.1186/s12879-022-07228-2

Similar Items

Similar Items